Glenmark, Shasun partner to develop and market generics in US
Mumbai-based Glenmark Pharma Ltd and Shasun Chemicals and Drugs Ltd have entered into a collaboration agreement for the joint development, filling and marketing of twelve generic pharmaceutical products for the US market.

Ranbaxy files two anti-retrovirals agents with WHO
Pharma major Ranbaxy Laboratories has made two further filings of its anti-retrovirals (ARVs) agents, to the World Health Organisation (WHO) for its approval, taking the total number of filings submitted with the WHO, to five.

Strides Arcolab inaugurates its new R&D facility
City-based Strides Arcolab Ltd has commissioned its state-of-the-art global pharmaceutical research centre. The R&D centre was inaugurated by T C Venkat Subramanian, chairman and managing director, Export-Import Bank of India recently here.

Ranbaxy-NHS settlement at £4.5 million
Ranbaxy Laboratories and the UK Department of Health announced that the Indian major will pay the UK’s National Health Service (NHS) £4.5 million (Rs 38.5 crore) to settle a price-fixing lawsuit. The company will make the payment without admission of liability and will co-operate in ongoing proceedings.